Expert Recommendations for the Diagnosis, Treatment, and Management of Adult B-Cell Acute Lymphoblastic Leukemia in Latin America

Autor: Ana Lisa Basquiera, Maria Cristina Seiwald, Carlos Roberto Best Aguilera, Leonardo Enciso, Isolda Fernandez, Angela Marie Jansen, Elenaide Nunes, Matias Sanchez del Villar, Victor I. Urbalejo Ceniceros, Vanderson Rocha

Publikováno v: JCO Global Oncology, Vol , Iss 9 (2023)

PURPOSEDespite strong induction chemotherapy response rates, only 30%-40% of patients with adult B-cell acute lymphoblastic leukemia (ALL) attain long-term remission. This study analyzes ALL in Latin America (LA) and recommends diagnosis, treatment,

Externí odkaz: https://doaj.org/article/6c0174ea76ec4fbbaa33a2112183f85b

Clinical significance of mitochondrial DNA content in acute promyelocytic leukaemia

Autor: Diego A. Pereira‐Martins, Juan L. Coelho‐Silva, Isabel Weinhäuser, Pedro L. Franca‐Neto, Douglas R. Silveira, César Ortiz, Amanda Moreira‐Aguiar, Marinus M. Lima, Luisa C. Koury, Raul A. de Melo, Ana B. Glória, Evandro M. Fagundes, Bruno K. Lino, Katia Pagnano, Rosane Bittencourt, Elenaide Nunes, Fabiola Traina, Lorena Figueiredo‐Pontes, Armand Keating, Martin S. Tallman, Raul C. Ribeiro, Richard Dilon, Arnold Ganser, Miguel A. Sanz, Nancy Berliner, Peter Valk, Bob Löwenberg, Tiziana Ottone, Nelida I. Noguera, Maria T. Voso, Francesca Paoloni, Paola Fazi, Emanuele Ammatuna, Gerwin Huls, Jan Jacob Schuringa, Eduardo M. Rego, Antonio R. Lucena‐Araujo

Publikováno v: British Journal of Haematology, 200(2), 170-174. Wiley-Blackwell Publishing Ltd
British Journal of Haematology, 200(2), 170-174. Wiley

Although a growing body of evidence demonstrates that altered mtDNA content (mtDNAc) has clinical implications in several types of solid tumours, its prognostic relevance in acute promyelocytic leukaemia (APL) patients remains largely unknown. Here,

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b6d4c4270bd170e7b621c9553c38e646
https://pure.eur.nl/en/publications/0c0bdef6-9f6c-4fba-ba95-d694023e4b02

STMN1 is highly expressed and contributes to clonogenicity in acute promyelocytic leukemia cells

Autor: Hugo Passos, Vicari, Juan Luiz, Coelho-Silva, Diego A, Pereira-Martins, Antônio Roberto, Lucena-Araujo, Keli, Lima, Jean Carlos, Lipreri da Silva, Priscila Santos, Scheucher, Luisa C, Koury, Raul A, de Melo, Rosane, Bittencourt, Katia, Pagnano, Elenaide, Nunes, Evandro M, Fagundes, Fabio, Kerbauy, Lorena Lobo, de Figueiredo-Pontes, Leticia Veras, Costa-Lotufo, Eduardo Magalhães, Rego, Fabiola, Traina, João Agostinho, Machado-Neto

Publikováno v: Investigational new drugs. 40(2)

Stathmin 1 (STMN1) is a microtubule-destabilizing protein highly expressed in hematological malignancies and involved in proliferation and differentiation. Although a previous study found that the PML-RARα fusion protein, which contributes to the pa

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::51a6536ad840ed827aee8e8283df0ee8
https://pubmed.ncbi.nlm.nih.gov/34837603

Evolution of myelodisplasic syndrome with ring sideroblasts (MDS-RS) to systemic mastocytosis and aleukemic mast cell leukemia

Autor: Costa, Larissa da, Azambuja, Ana Paula de, Ângelo Lisboa, Erica Sabrine, Bueno, Silvia Natalia, Coutinho, Elenaide Nunes, Spinelli, Bruno Francisco Buzinetti, Medeiros, Larissa Alessandra, Funke, Vaneuza de Araujo Moreira, Malvezzi, Mariester

Publikováno v: Hematology, Transfusion and Cell Therapy, Volume: 42, Issue: 4, Pages: 387-389, Published: 07 DEC 2020

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______608::cd0c568a2b1ca59b59dd7b0ac15b1c0a
http://www.scielo.br/scielo.php?script=sci_arttext&pid=S2531-13792020000400387&lng=en&tlng=en

Evolution of myelodisplasic syndrome with ring sideroblasts (MDS-RS) to systemic mastocytosis and aleukemic mast cell leukemia.

Autor: Costa LD; Hospital de Clínicas da Universidade Federal do Paraná (HC UFPR), Curitiba, PR, Brazil. Electronic address: larissadacosta1@hotmail.com., Azambuja AP; Hospital de Clínicas da Universidade Federal do Paraná (HC UFPR), Curitiba, PR, Brazil., Ângelo Lisboa ES; Hospital de Clínicas da Universidade Federal do Paraná (HC UFPR), Curitiba, PR, Brazil., Bueno SN; Hospital de Clínicas da Universidade Federal do Paraná (HC UFPR), Curitiba, PR, Brazil., Coutinho EN; Hospital de Clínicas da Universidade Federal do Paraná (HC UFPR), Curitiba, PR, Brazil., Spinelli BFB; Hospital de Clínicas da Universidade Federal do Paraná (HC UFPR), Curitiba, PR, Brazil., Medeiros LA; Hospital de Clínicas da Universidade Federal do Paraná (HC UFPR), Curitiba, PR, Brazil., Funke VAM; Hospital de Clínicas da Universidade Federal do Paraná (HC UFPR), Curitiba, PR, Brazil., Malvezzi M; Hospital de Clínicas da Universidade Federal do Paraná (HC UFPR), Curitiba, PR, Brazil.

Publikováno v: Hematology, transfusion and cell therapy [Hematol Transfus Cell Ther] 2020 Oct - Dec; Vol. 42 (4), pp. 387-389. Date of Electronic Publication: 2019 Oct 10.